InvestorsHub Logo
Followers 19
Posts 4745
Boards Moderated 0
Alias Born 11/10/2016

Re: None

Thursday, 08/17/2017 10:13:58 PM

Thursday, August 17, 2017 10:13:58 PM

Post# of 144814
A game changing technology for cell therapies

Step back and look again

Take a wider view in this. It's too easy to get lost in the daily fears and concerns and miss the big picture.

The encapsulation of cells is the next frontier in medicine, especially stem cells.

We own 14% of the company which owns the best encapsulation technology in the world. It's unique. It's bioinert, retrievable, avoids fibrosis and can be frozen to allow distribution.

There's nothing else like it.

Cell based treatments are the future and big pharmacyte knows this.

We have a way of directly attacking tumors right beside them and without side effects. Amazing

We have a way of putting insulin creating cells into the body to cure diabetes. Amazing

We are creating our cell banks for a pivotal clinical trial in pancreatic cancer. Pivotal. Agreed by the FDA.

We have an amazing team of world class doctors and oncologists involved and a consortium of the world's best advising the progress of our technology in cancer and diabetes.

Johnson and Johnson, novo nordisk and many diabetes organizations see cell encapsulation as the biggest hope for a cure for diabetes. The problem has been the immune system attacking those caps.

Pharmacyte and ciab have the only commercially viable solution to that which doesn't involve implants or surgery and all the problems associated with that. Because our encapsulation can be frozen and transported. It's unique.

Of course big pharmacyte will want this? The question is how much will they pay and can kw salmon and gunzberg start a bidding war? After the PIVOTAL ind for pancreatic cancer has been accepted by the FDA we will be ready for funding. Talks are continuing to take place for funding with millions expected for us.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News